Device‐Induced Thrombosis in Blood‐Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies
Advanced Healthcare Materials · 2026-06 · 15 (23)
DOI: 10.1002/adhm.202505409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.04.2026. Verfasst von Constant Gillot und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute For Life Sciences, Namur Thrombosis and Hemostasis Center, University of…. Hauptthemen laut MEDLINE: Thrombosis, Equipment and Supplies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 267 Literaturangaben.
Abstract (Originalsprache)
Medical devices such as catheters, vascular grafts, and extracorporeal circuits play a vital role in modern clinical care but remain limited by the persistent risk of device‐related thrombosis. This review explores the multifaceted mechanisms driving device‐induced thrombosis, emphasizing the pivotal role of the contact activation pathway (factors XII and XI), leukocyte adhesion, complement system activation, and red blood cell hemolysis. This paper details how protein adsorption, especially fibrinogen and contact factors, initiates a cascade of platelet activation and coagulation, leading to thrombus formation on artificial surfaces. In response, diverse prevention strategies have emerged, including passive surface modifications (e.g., PEG, PEO, pyrolytic carbon), bioactive coatings (e.g., heparin, thrombomodulin, nitric oxide‐releasing polymers), and novel approaches like endothelialization and stimuli‐responsive materials. Additionally, pharmacologic innovations targeting the contact system via antisense oligonucleotides, monoclonal antibodies, aptamers, and natural protease inhibitors show promise for reducing thrombosis risk while preserving hemostasis. Integrating these strategies with advanced in vitro evaluation platforms and AI‐assisted data integration and analysis marks a new era in the development of hemocompatible biomaterials. This review underscores the need for multidisciplinary efforts to design the next generation of blood‐contacting medical devices with enhanced safety, efficacy, and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute For Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.
- Clinical Chemistry Department, Centre Hospitalier Universitaire Liège, Liège, Belgium.
- Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.
ORCID-Profile: Constant Gillot, Jonathan Douxfils
Zitieren
APA
Gillot, C., Michaux, P., Evrard, J., de Vriese, M., Bouarroudj, H., Morimont, L., Dogné, J. M., & Douxfils, J. (2026). Device‐Induced Thrombosis in Blood‐Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies. Advanced Healthcare Materials, 15(23). https://doi.org/10.1002/adhm.202505409
Vancouver
Gillot C, Michaux P, Evrard J, de Vriese M, Bouarroudj H, Morimont L, et al. Device‐Induced Thrombosis in Blood‐Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies. Advanced Healthcare Materials. 2026;15(23). doi:10.1002/adhm.202505409
BibTeX
@article{Gillot2026,
author = {Gillot, Constant and Michaux, Pauline and Evrard, Jonathan and de Vriese, Marie and Bouarroudj, Hachem and Morimont, Laure and Dogné, Jean-Michel and Douxfils, Jonathan},
title = {Device‐Induced Thrombosis in Blood‐Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {23},
doi = {10.1002/adhm.202505409}
}
EUVIMED